Benitec Biopharma Limited (NASDAQ:BNTC)

Benitec Biopharma Limited (NASDAQ:BNTC) represented a move of 0 percent or $0 per share and closed its previous day trading session at $2.04. 0 Shares were traded in the last trading session with an Average Volume of 7.14 Million Shares. The stock currently has a Market Capitalization of 524.34 Million.

Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.

The stock traded between $1.85 and $4.90 over 1-Year time period showing its price to sales ratio of 153.55. Benitec Biopharma Limited (NASDAQ:BNTC) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-13.5 and 200-Day Simple Moving Average of $-23.73. Its Price to Free Cash Flow is 0 and Price to Book of 1.89.

Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.

Neonode Inc. (NASDAQ:NEON)

In the last trading session, Neonode Inc. (NASDAQ:NEON) added its value by 0% closing at the price of $1.6. The stock currently has market capitalization of 9.98 Million, with average volume of 44.33 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Neonode Inc. (NASDAQ:NEON) is showing beta of 1.18. This particular value of beta suggests that Neonode Inc. (NASDAQ:NEON) has historically moved 118% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Neonode Inc. (NASDAQ:NEON) is at $-0.71.

The stock currently has RSI of 35.43. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Neonode is a company that designs, develops and sells patented technologies and products focused on unique user experiences. With offices in Stockholm, Sweden and San Ramon, California, Neonode Inc. is a company with licenses and products sold worldwide through both direct web sales and local distribution partners.

Neonode Inc. (NASDAQ:NEON) topped its 52-week high price of $9.95 on 12/07/17 and 52-Week Low Price of $1.31 on 11/15/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.74% and monthly volatility of 12.07% respectively.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *